白细胞介素-4、瘦素、趋化素与肥胖型哮喘患儿病情程度的关系及预测哮喘控制的价值

Relationships of interleukin-4, leptin and chemerin with severity of asthma in obese children and their predictive values for asthma control

  • 摘要:
    目的 探讨血清白细胞介素-4(IL-4)、瘦素(Leptin)、趋化素(Chemerin)水平与肥胖型哮喘患儿病情程度的相关性及其预测哮喘控制的价值。
    方法 选取102例肥胖型哮喘患儿为研究组,另选取102例健康肥胖儿童作为对照组,比较2组血清IL-4、Leptin、Chemerin水平。将研究组根据病情程度分为轻度组34例、中度组42例、重度组26例,比较各组血清IL-4、Leptin、Chemerin水平。分析血清IL-4、Leptin、Chemerin与病情程度的相关性。治疗4周后,将102例患儿根据哮喘控制情况分为控制组82例、未控制组20例,比较2组临床资料,血清IL-4、Leptin、Chemerin水平,并分析其对哮喘控制的影响。评价血清IL-4、Leptin、Chemerin水平对哮喘控制的预测价值。
    结果 血清IL-4、Leptin、Chemerin水平在对照组儿童、轻度哮喘患儿、中度哮喘患儿、重度哮喘患儿中呈逐渐升高趋势,差异均有统计学意义(P < 0.001)。Spearman相关性分析显示,血清IL-4、Leptin、Chemerin与病情程度呈正相关(P < 0.001)。未控制组血清IL-4、Leptin、Chemerin水平高于控制组,差异均有统计学意义(P < 0.001)。Logistic回归分析显示,校正病程后的血清IL-4(OR=1.514, 95%CI: 1.117~2.051)、Leptin(OR=1.534, 95%CI: 1.234~1.907)、Chemerin(OR=1.418, 95%CI: 1.026~1.959)仍是哮喘控制的独立危险因素(P < 0.05)。血清IL-4、Leptin、Chemerin单项及联合预测哮喘控制的曲线下面积(AUC)分别为0.807(95%CI: 0.717~0.879)、0.801(95%CI: 0.711~0.874)、0.834(95%CI: 0.748~0.901)、0.932(95%CI: 0.864~0.972), 联合预测的AUC优于各指标单独预测(P < 0.05)。
    结论 肥胖型哮喘患儿血清IL-4、Leptin、Chemerin水平与病情程度呈正相关,且为哮喘控制的独立危险因素。3项指标联合预测哮喘控制的价值更高。

     

    Abstract:
    Objective To explore the correlations of serum interleukin-4 (IL-4), leptin and chemerin levels with severity of asthma in obese children and their predictive values for asthma control.
    Methods A total of 102 obese children with asthma were selected as study group, and another 102 healthy obese children were selected as control group. The serum levels of IL-4, leptin and chemerin were compared between the two groups. The study group was divided into mild (n=34), moderate (n=42) and severe (n=26) asthma groups based on severity of disease, and the serum levels of IL-4, leptin and chemerin were compared among different groups. The correlations of serum IL-4, leptin and chemerin with disease severity were analyzed. After 4 weeks of treatment, the 102 children with asthma were divided into controlled group (n=82) and uncontrolled group (n=20) based on asthma control status. Clinical data and serum levels of IL-4, leptin and chemerin were compared between the two groups, and their impacts on asthma control were analyzed. The predictive values of serum IL-4, leptin and chemerin levels for asthma control were evaluated.
    Results The serum levels of IL-4, leptin and chemerin showed significant gradual increase trends among controlled children, mild asthma children, moderate asthma children, and severe asthma children (P < 0.001). Spearman correlation analysis showed positive correlations of serum IL-4, leptin and chemerin with disease severity (P < 0.001). The serum levels of IL-4, leptin and chemerin in the uncontrolled group were significantly higher than those in the controlled group (P < 0.001). Logistic regression analysis showed that serum IL-4 (OR=1.514, 95%CI, 1.117 to 2.051), leptin (OR=1.534, 95%CI, 1.234 to 1.907), and chemerin (OR=1.418, 95%CI, 1.026 to 1.959) after adjusting for disease duration were still the independent risk factors for asthma control (P < 0.05). The areas under the curve (AUC) for predicting asthma control by single and combined detections of serum IL-4, leptin and chemerin were 0.807 (95%CI, 0.717 to 0.879), 0.801 (95%CI, 0.711 to 0.874), 0.834 (95%CI, 0.748 to 0.901) and 0.932 (95%CI, 0.864 to 0.972), respectively. The AUC for combined prediction was significantly better than that for individual predictor (P < 0.05).
    Conclusion The serum levels of IL-4, leptin and chemerin in obese children with asthma are positively correlated with disease severity, and they are independent risk factors for asthma control. Combined detection of these three indicators has a higher predictive value for asthma control.

     

/

返回文章
返回